Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and gastrointestinal pharmacodynamics
(stool frequency, stool consistency, stool ease of passage, stool completeness of evacuation)
of MD-1100 acetate administered daily for 14 days.